A Look At Commvault Systems (CVLT) Valuation After Earnings And New Fiscal 2027 Guidance

Advertisement

What the latest earnings and guidance tell you about Commvault Systems (CVLT)

Commvault Systems (CVLT) has drawn fresh attention after reporting fourth quarter and full year results that paired higher revenue with lower net income, alongside new fiscal 2027 guidance and an update on share repurchases.

See our latest analysis for Commvault Systems.

Commvault Systems' share price has moved sharply in recent weeks, with a 30.53% 1 month share price return and 20.11% 3 month share price return. However, a 16.75% year to date share price decline and 40.85% 1 year total shareholder return loss show that recent momentum is still working against a weaker longer term picture.

After strong recent swings in Commvault following earnings, you may want to widen your watchlist through our screen of 60 profitable AI stocks that aren't just burning cash

With revenue higher, earnings softer and fresh guidance in place, the latest move in Commvault raises a key question for you as an investor: is the stock still undervalued, or is the market already pricing in future growth?

Most Popular Narrative: 24.2% Undervalued

Commvault Systems' most followed narrative pegs fair value at $136.46, above the last close of $103.38, which frames the latest earnings reaction in a different light.

Rapid expansion and successful cross-sell/upsell momentum within the SaaS (Metallic) platform, evidenced by 63% SaaS ARR growth, a 45% increase in multi-product customers, and 125% SaaS net dollar retention, point to continued improvement in the quality and predictability of future revenues, directly supporting margin expansion and higher earnings visibility.

Read the complete narrative.

Curious what revenue mix, margin assumptions and future earnings multiple sit behind that fair value gap? The narrative leans on ambitious growth, richer recurring revenue and a premium valuation profile that many investors usually associate with top tier software stocks.

The narrative uses a 9.08% discount rate and blends revenue growth, margin expansion and cash flow expectations into a single fair value estimate of $136.46. Against the $103.38 share price, it points to meaningful implied upside, but ultimately it is your call whether those underlying assumptions look realistic or too optimistic for your own risk tolerance and time horizon. Result: Fair Value of $136.46 (UNDERVALUED)

Have a read of the narrative in full and understand what's behind the forecasts.

However, those fair value assumptions can quickly look fragile if SaaS margin pressure persists, or if large, late-quarter deals and potential M&A activity create bumpier earnings than expected.

Find out about the key risks to this Commvault Systems narrative.

Another way to look at valuation

So far the focus has been on cash flow based fair value, which points to Commvault Systems trading below estimated future cash flow value at $166.46 per share and 37.9% below an internal fair value estimate. On that view, the SWS DCF model suggests the stock looks undervalued.

The catch is that any DCF output depends heavily on long term revenue, margin and discount rate assumptions. If those inputs prove too optimistic, the implied upside could narrow quickly. The key question is how much weight to put on a model that relies on forecasts several years out.

Look into how the SWS DCF model arrives at its fair value.

CVLT Discounted Cash Flow as at May 2026
CVLT Discounted Cash Flow as at May 2026

Next Steps

If this mix of risks and rewards feels finely balanced, now is a good time to review the full picture and decide where you stand with 2 key rewards and 2 important warning signs

Looking for more investment ideas?

If Commvault is only one piece of your portfolio puzzle, now is the time to line up a few more ideas so you are not relying on a single stock.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

New: AI Stock Screener & Alerts

Our new AI Stock Screener scans the market every day to uncover opportunities.

• Dividend Powerhouses (3%+ Yield)
• Undervalued Small Caps with Insider Buying
• High growth Tech and AI Companies

Or build your own from over 50 metrics.

Explore Now for Free

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com

About NasdaqGS:CVLT

Commvault Systems

Provides cyber resiliency solutions for enterprises to protect, secure, and recover data, applications, and identity system.

Excellent balance sheet with moderate growth potential.

Advertisement

Weekly Picks

LO
Lou_Basenese
OPTH logo
Lou_Basenese on Optimi Health ·

The Only Psychedelic Company Already Selling MDMA and Psilocybin to Real Patients, Yet Priced Like It Doesn’t Exist

Fair Value:US$1157.5% undervalued
48 users have followed this narrative
2 users have commented on this narrative
8 users have liked this narrative
WE
WealthAP
NOVO B logo
WealthAP on Novo Nordisk ·

Novo Nordisk (NVO): Is the "Easy Growth" Story Over?

Fair Value:DKK 407.7721.4% undervalued
69 users have followed this narrative
0 users have commented on this narrative
8 users have liked this narrative
VA
ValueInvestingSubstack
ZTS logo
ValueInvestingSubstack on Zoetis ·

Zoetis down -50% over the past year

Fair Value:US$92.9218.9% undervalued
23 users have followed this narrative
0 users have commented on this narrative
9 users have liked this narrative
CE
CentryResearch
LEU logo
CentryResearch on Centrus Energy ·

Centrus Energy: The Next Nuclear Bottleneck Isn't Reactors. It's Fuel.

Fair Value:US$19013.7% undervalued
24 users have followed this narrative
0 users have commented on this narrative
10 users have liked this narrative

Updated Narratives

WI
WisetoWealth
PYPL logo
WisetoWealth on PayPal Holdings ·

The Underrated Transformation of a Digital Payments Giant

Fair Value:US$90.3137.8% undervalued
4 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
BL
Blagget
TERA logo
Blagget on Terra Balcanica Resources ·

The C$4M Explorer Positioned to Become Europe's First Antimony Mine

Fair Value:CA$0.487.5% undervalued
3 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
DA
CHTR logo
david_6nroa on Charter Communications ·

Charter is undervalued - Here's why.

Fair Value:US$87.0741.6% overvalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative

Popular Narratives

CU
MSFT logo
CubanEros on Microsoft ·

A wonderful business at reasonable price.

Fair Value:US$419.919.1% undervalued
81 users have followed this narrative
0 users have commented on this narrative
6 users have liked this narrative
OS
oscargarcia
NVDA logo
oscargarcia on NVIDIA ·

The company that went from selling GPUs to gamers to becoming the AI arms dealer of the 21st century.

Fair Value:US$28026.1% undervalued
188 users have followed this narrative
9 users have commented on this narrative
15 users have liked this narrative
BE
PYPL logo
benjamin_lvieq on PayPal Holdings ·

PayPal: PayPal Doesn't Need to Grow – It Needs to Stop Falling – A Mispriced Cash Machine With a Cannibal Buyback

Fair Value:US$6513.6% undervalued
72 users have followed this narrative
2 users have commented on this narrative
11 users have liked this narrative

Trending Discussion

DE
TDOC logo
derek_3wsdg on Teladoc Health ·

You’ve overlooked the activist investor factor. Travis Cocke’s Voss has announced 5% ownership through a 13G filing. They’ve added to that 5% since, and in doing so, have created a structural trap door for 27.42 Million Shares actively sold short. Chuck will announce lots of positives on July 29 but it’s what Voss announces shortly after that will rock the overextended Teledoc shorts. The Walmart partnership is the tip of the iceberg. The market is missing the sheer regulatory and enterprise friction of modern corporate healthcare. Teladoc isn't a "consumer app"; it is the primary digital infrastructure integrated directly into the legacy backends of Tier-1 insurance companies and fortune 500 employers, covering 105 million+ lives. Teladoc is acting as the digital top-of-funnel engine for the world's largest retailer. If Voss pushes the narrative that Teladoc is effectively the outsourced digital brain of Walmart's entire healthcare footprint, the fair value shifts from a basic health multiple to an enterprise distribution premium. Additionally , we are in a structural gold rush for high-quality, legally compliant, longitudinal medical data to train vertical healthcare AI models. Large technology hyperscalers and pharmaceutical giants cannot simply scrape the internet for this; they need structured clinical inputs. Teladoc sits on one of the largest de-identified virtual medical datasets on earth. From the activist playbook , we’ll see Voss demand the immediate creation of a Data & Diagnostics Licensing Division, transforming a legacy liability into an incredibly high-margin, pure-software data asset that requires zero human clinician hours to scale. Chuck is doing great work and deserves credi5 for the Teledoc turnaround but it will be Travis Cocke who will be responsible for a share price way beyond your $15 valuation.

1
|
0